Updated Jul 16, 2026
Carter Robert Ross has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $879.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | TOI | Oncology Institute, Inc. | J — Other acquisition / disposition | 1.6K | $4.47 | $7K |
| 2026-04-02 | TOI | Oncology Institute, Inc. | J — Other acquisition / disposition | 20.3K | $3.07 | $62K |
| 2026-04-02 | TOI | Oncology Institute, Inc. | A — Grant or award | 202.9K | $0.00 | |
| 2026-03-18 | TOI | Oncology Institute, Inc. | J — Other acquisition / disposition | 1.3K | $3.59 | $5K |
| 2026-01-06 | TOI | Oncology Institute, Inc. | J — Other acquisition / disposition | 244 | $3.67 | $895 |
| 2026-01-05 | TOI | Oncology Institute, Inc. | S — Open-market sale | 247 | $3.56 | $879 |
| 2025-11-19 | TOI | Oncology Institute, Inc. | A — Grant or award | 195 | $0.00 | |
| 2024-11-21 | TOI | Oncology Institute, Inc. | D — Derivative transaction | 235 | $0.14 | $32 |
Carter Robert Ross is a corporate insider — currently tracked as Chief Financial Officer of Oncology Institute, Inc. (TOI). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($879) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Carter Robert Ross profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.